Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Code Biotherapeutics
2801 Sterling Drive
Hatfield, PA 19440
Phone: 215-996-3006
https://www.codebiotx.com/

Code Bio is a biotechnology company pioneering the development of genetic medicines to treat and potentially cure serious and life-threatening genetic diseases. By leveraging its novel non-viral multivalent synthetic DNA delivery platform, 3DNA, Code Bio's approach can overcome multiple challenges inherent with viral-based delivery approaches, including immunogenicity, size and delivery limitations, inability to re-dose and manufacturing complexity.

Key Contact
Name
Brian P. McVeigh
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
06/09/22 $75,000,000 Series A 4BIO Capital
Amgen Ventures
CureDuchenne Ventures
Hatteras Venture Partners
JDRF T1D Fund
New Enterprise Associates
Northpond Ventures
Takeda Ventures
UCB Ventures
UPMC Enterprise
undisclosed